| Modera Gi | |
|
5575 Frisco Square Blvd 220 Frisco TX 75034-3303 | |
| (469) 920-2302 | |
| Not Available |
| Full Name | Modera Gi |
|---|---|
| Speciality | Internal Medicine |
| Location | 5575 Frisco Square Blvd, Frisco, Texas |
| Authorized Official Name and Position | Trevor Huber (PRESIDENT) |
| Authorized Official Contact | 9729870458 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Modera Gi 5575 Frisco Square Blvd #220 Frisco TX 75034-3303 Ph: (469) 920-2302 | Modera Gi 5575 Frisco Square Blvd 220 Frisco TX 75034-3303 Ph: (469) 920-2302 |
| NPI Number | 1063142115 |
|---|---|
| Provider Enumeration Date | 06/13/2022 |
| Last Update Date | 10/04/2023 |
| Medicare PECOS PAC ID | 7517334741 |
|---|---|
| Medicare Enrollment ID | O20221101002038 |
News Archive
Organ donation after circulatory death (DCD), in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation. Currently, the use of livers from DCD donors remains controversial, particularly with donors with advanced age.
Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063142115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Amir Ahmed |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205824810 PECOS PAC ID: 0244210151 Enrollment ID: I20040730000829 |
News Archive
Organ donation after circulatory death (DCD), in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation. Currently, the use of livers from DCD donors remains controversial, particularly with donors with advanced age.
Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
› Verified 1 days ago
| Provider Name | David P Lee |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1992064976 PECOS PAC ID: 9032419296 Enrollment ID: I20151120000391 |
News Archive
Organ donation after circulatory death (DCD), in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation. Currently, the use of livers from DCD donors remains controversial, particularly with donors with advanced age.
Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
› Verified 1 days ago
| Provider Name | Trevor K Huber |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649682857 PECOS PAC ID: 2264723618 Enrollment ID: I20160615002044 |
News Archive
Organ donation after circulatory death (DCD), in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation. Currently, the use of livers from DCD donors remains controversial, particularly with donors with advanced age.
Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
› Verified 1 days ago
| Provider Name | Neema M Saraiya |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1851736078 PECOS PAC ID: 6800197757 Enrollment ID: I20191024002694 |
News Archive
Organ donation after circulatory death (DCD), in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation. Currently, the use of livers from DCD donors remains controversial, particularly with donors with advanced age.
Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
› Verified 1 days ago
News Archive
Organ donation after circulatory death (DCD), in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation. Currently, the use of livers from DCD donors remains controversial, particularly with donors with advanced age.
Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.
In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
› Verified 1 days ago
Healthtexas Provider Network Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5575 Warren Pkwy, Ste. 115, Frisco, TX 75034 Phone: 972-712-3652 Fax: 214-618-3614 | |
Diagnostic Partners Of North Texas, P.a. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5140 Legendary Dr Ste 100, Frisco, TX 75034 Phone: 972-867-9507 Fax: 972-578-7705 | |
Obiora M Ekweani Md, Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3220 Parkwood Blvd, Frisco, TX 75034 Phone: 972-668-3990 Fax: 972-668-3991 | |
North Texas Endocrinology And Diabetes Center, P.a. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 14725 Lebanon Road, Suite 100, Frisco, TX 75035 Phone: 214-705-9000 Fax: 214-619-5675 | |
Legacy Physicians Group Florida Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7460 Warren Parkway, Suite 160, Frisco, TX 75034 Phone: 972-668-5400 Fax: 972-668-5401 | |
Arshad Khalil Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 15177 Snowshill Dr, Frisco, TX 75035 Phone: 469-795-6002 | |
Healthcare Associates Of Frisco Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4500 Hillcrest Road, Suite 1200, Frisco, TX 75035 Phone: 214-297-3000 Fax: 214-297-3006 |